EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction

Gynecologic Oncology

Volumn 104, Issue 1, 2007, Pages 109-113

  Oonk, M H M ^a   de Bock, G H ^a   van der Veen, D J ^b   ten Hoor, K A ^a   de Hullu, J A ^c   Hollema, H ^a   van der Zee, A G J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Epidermal growth factor receptor; Lymphatic metastases; Vulvar cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INGUINAL LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; VULVA CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INGUINAL CANAL; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL; VULVAR NEOPLASMS;

EID: 33846018072     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.07.035     Document Type: Article

References (23)

1. Hacker N.F. Vulvar cancer. In: Berek J.S., and Hacker N.F. (Eds). Practical gynecologic oncology. 3rd ed. (2000), Williams and Wilkins, Baltimore 553-596
2. Prodratz K.C., Symmonds R.E., Taylor W.F., and Williams T.J. Carcinoma of the vulva: analysis of treatment and survival. Obstet. Gynecol. 61 (1983) 63-74
3. Andersen B.L., and Hacker N.F. Psychosexual adjustment after vulvar surgery. Obstet. Gynecol. 62 (1983) 457-462
4. Stehman F.B., Bundy B.N., Ball H., and Clarke-Pearson D.L. Sites of failure and times to failure in carcinoma of the vulva treated conservatively: a Gynecologic Oncology Group study. Am. J. Obstet. Gynecol. 174 (1996) 1128-1132
5. Oonk M.H.M., Hollema H., de Hullu J.A., and van der Zee A.G.J. Prediction of lymph node metastases in vulvar cancer, a review. Int J Gynaecol Cancer 16 (2006) 963-971
6. De Hullu J.A., Hollema H., Piers D.A., et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J. Clin. Oncol. 18 (2000) 2811-2816
7. Moore R.G., DePasquale S.E., Steinhoff M.M., et al. Sentinel node identification and the ability to detect metastatic tumor to inguinal lymph nodes in squamous cell cancer of the vulva. Gynecol. Oncol. 89 (2003) 475-479
8. Puig-Tintoré L.M., Ordi J., Vidal-Sicart S., et al. Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma. Gynecol. Oncol. 88 (2003) 29-34
9. Hacker N.F., Berek J.S., Lagasse L.D., Nieberg R.K., and Leuchter R.S. Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet. Gynecol. 63 (1984) 155-162
10. Magrina J.F., Webb M.J., Gaffey T.A., and Symmonds R.E. Stage I squamous cell cancer of the vulva. Am. J. Obstet. Gynecol. 134 (1979) 453-459
11. Ross M.J., and Ehrmann R.L. Histologic prognosticators in stage I squamous cell carcinoma of the vulva. Obstet. Gynecol. 70 (1987) 774-784
12. Boyce J., Fruchter R.G., Kasambilides E., Nicastri A.D., Sedlis A., and Remy J.C. Prognostic factors in carcinoma of the vulva. Gynecol. Oncol. 20 (1985) 364-377
13. Andreasson B., and Nyboe J. Predictive factors with reference to low-risk of metastases in squamous carcinoma of the vulvar region. Gynecol. Oncol. 21 (1985) 196-206
14. Johnson G.A., Mannel R.M., Khalifa M., Walker J.L., Wren M., Kyung-Whan M., et al. Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival. Gynecol. Oncol. 65 (1997) 425-429
15. Shepherd J.H. Cervical and vulvar cancer: changes in FIGO definitions of staging. Br. J. Obstet. Gynaecol. 103 (1996) 405-406
16. Vulva. American Joint Committee on Cancer: AJCC cancer staging manual. 5th ed. (1997), Lippincott-Raven, Philadelphia 181-184
17. Fu Y.S., and Reagan J.W. Pathology of the uterine cervix, vagina, and vulva (1989), Saunders, Philadelphia 169
18. De Hullu J.A., Hollema H., Lolkema S., Boezen M., Boonstra H., Burger M.P., et al. Vulvar carcinoma. The price of less radical surgery. Cancer 11 (2002) 2331-2338
19. Berchuck A., Rodriguez G., Kamel A., Soper J.T., Clarke-Pearson D.L., and Bast Jr. R.C. Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina. Obstet. Gynecol. 76 (1990) 381-387
20. Pfeiffer D., Stellwag B., Pfeiffer A., Borlinghaus P., Meier W., and Scheidel P. Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix. Gynecol. Oncol. 33 (1989) 146-150
21. Hale R.J., Buckley C.H., Gullick W.J., Fox H., Williams J., and Wilcox F.L. Prognostic value of epidermal growth factor receptor expression in cervical carcinoma. J. Clin. Pathol. 46 (1993) 149-153
22. Kersemaekers A.M., Fleuren G.J., Kenter G.G., van den Broek L.J., Uljee S.M., Hermans J., et al. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis. Clin. Cancer Res. 5 (1999) 577-586
23. Khalifa M.A., Abdoh A.A., Mannel R.S., Haraway S.D., Walker J.L., and Min K.W. Prognostic utility of epidermal growth factor receptor overexpression in endometrial adenocarcinoma. Cancer 73 (1994) 370-376